Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Aker BioMarine/

Library

Aker BioMarine

Aker BioMarine Website, Blog & Press Pages - aVenture Research

Library

akerbiomarine.comCrawled Nov 7, 2026

Topics

Publication type

Search the library

Content origin

Row density

Product

6 pages

AKBM: Videos/videos
Video page for Aker BioMarine
Consumer Health Products/consumer-health-products
Lang Pharma Nutrition leverages 35 years of experience in nutrition and dietary supplements, distributing through major US retail chains and its private-label brand, Kori Krill Oil.
Our products/our-products
The page describes Aker BioMarine’s products for people, pets, and fish.
The power of tiny krill/the-power-of-tiny-krill-0-0

Blog

6 pages

AKBM: New articles/new-articles
New articles and news from Aker BioMarine
Aker BioMarine blog/blog
The company explains the benefits of krill on its blog.
Healthy Aging Starts with the Brain: Exploring a New Approach to Cognitive Health/news/healthy-aging-starts-with-the-brain-exploring-a-new-approach-to-cognitive-health
Consumers are increasingly interested in proactive approaches that support brain health not only when concerns arise, but as part of a broader strategy for maintaining cognitive function throughout life.
New study confirms growth effect of astaxanthin krill oil on Pacific white shrimp/news/new-study-confirms-growth-effect-of-astaxanthin-krill-oil-on-pacific-white-shrimpc3135409
A study in the *Journal of Applied Aquaculture* examines whether astaxanthin krill oil and soybean oil can offset high salinity in shrimp farming.

Press

6 pages

Aker BioMarine Events/aker-biomarine-events
Events for Aker BioMarine and brands
Aker BioMarine News/news
Aker BioMarine is a company in constant development. Here is the latest news and press releases.
Aker BioMarine Nyheter/nyheter
Antarctic Endurance/antarctic-endurance

Careers & Hiring

2 pages

Caring for Talent/caring-for-talent
People are the heart of Aker BioMarine, which is why attracting, fostering, and building talent are key to the company’s success.
Corporate culture/open-corporate-culture
Aker BioMarine corporate culture and whistleblowing channel

About

6 pages

CSR/corporate-social-responsibility
Aker Biomarines Corporate Social Responsibility
Ecosystem/sustainability-ecosystem
Scientific research, conducted over several years, has consistently demonstrated the high abundance of krill in the Antarctic ecosystem.
Main Shareholders/main-shareholders
Sustainability/sustainability
Aker BioMarine aims to address global challenges beyond its role as a supplier and producer of marine ingredients.

Contact

3 pages

AKBM: Raising a Concern/raising-a-concern
Raising a Concern
Contact Us/contact-us
The company responds to inquiries through a contact form.
Media Contacts/media-contacts
For media inquiries, please contact

Homepage

1 page

Homepage/
Aker BioMarine is a Norwegian biotech company and the leading supplier of krill and marine omega-3 ingredients: Superba, Lysoveta, PL+ and Revervia.

Privacy

1 page

Privacy Policy/privacy-policy
Aker BioMarine’s privacy policy protects the personal data of employees and business partners.

Terms & Conditions

2 pages

Copyright Terms and Conditions/copyright-terms-and-conditions
Aker BioMarine Ccopyright Conditions and Terms
Terms of consent/terms-of-consent